Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Belen Ferrer

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2004
Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid functionEmilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, et al.
Psychopharmacology|January 7, 2021
Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210Antonia Serrano, Evelyn Vadas, Belen Ferrer, et al.
European Journal of Pharmacology|February 13, 2007
Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypiesBelen Ferrer, Miguel Angel Gorriti, Ana Palomino, et al.
The Biochemical Journal|February 17, 2007
Regulation of brain anandamide by acute administration of ethanolBelen Ferrer, Francisco Javier Bermúdez-Silva, Ainhoa Bilbao, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2004
Experimental parkinsonism alters anandamide precursor synthesis, and functional deficits are improved by AM404: a modulator of endocannabinoid functionEmilio Fernandez-Espejo, Isabel Caraballo, Fernando Rodriguez de Fonseca, et al.
Psychopharmacology|January 7, 2021
Genetic deletion of dopamine D1 receptors increases the sensitivity to cannabinoid CB1 receptor antagonist-precipitated withdrawal when compared with wild-type littermates: studies in female mice repeatedly exposed to the Spice cannabinoid HU-210Antonia Serrano, Evelyn Vadas, Belen Ferrer, et al.
European Journal of Pharmacology|February 13, 2007
Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypiesBelen Ferrer, Miguel Angel Gorriti, Ana Palomino, et al.
The Biochemical Journal|February 17, 2007
Regulation of brain anandamide by acute administration of ethanolBelen Ferrer, Francisco Javier Bermúdez-Silva, Ainhoa Bilbao, et al.
Pageof 3